Clinical Trials Directory

Trials / Completed

CompletedNCT02654353

A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Johannes Gutenberg University Mainz · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a prospective randomized controlled trial that compares the conventional stepwise approach with a new sequential substrate ablation approach for persistent atrial fibrillation.

Detailed description

A total number of 100 patients with persistent AF were randomized to receive either conventional stepwise ablation (conventional group) or a sequential substrate ablation (substrate group), both with the endpoint of AF termination. All patients were in AF before the procedure. The sequential substrate ablation consisted of pulmonary vein isolation (PVI) followed by cardioversion and linear ablation at the mitral isthmus, left atrial roof and cavotricuspid isthmus in order to modify the AF substrate. After achievement of bidirectional block, AF was re-induced and electrogram-based ablation was performed to achieve AF termination to sinus rhythm (SR). Endpoints are single-procedure outcome and total amount of RF ablation time required to terminate AF by electrogram-guided ablation.

Conditions

Interventions

TypeNameDescription
PROCEDUREAblationIn both arms, patients will undergo an ablation procedure for persistent atrial fibrillation. The sequence of ablation steps are different between both arms.

Timeline

Start date
2012-02-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2016-01-13
Last updated
2016-01-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02654353. Inclusion in this directory is not an endorsement.